July 16, 2018
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- National Drug Code Directory (updated)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
- Drug Trial Snapshot: MEKTOVI
- Drug Trial Snapshot: BRAFTOVI
- FDA announces voluntary recall of several medicines containing valsartan following detection of an impurity
- Orange Book Patent Listing Dispute List (updated)
- Prinston Pharmaceutical Inc. Issues Voluntary Nationwide Recall of Valsartan and Valsartan HCTZ Tablets Due to Detection of a Trace Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA) in the Products
.png)
No hay comentarios:
Publicar un comentario